Sarepta Therapeutics
SRPT
#2537
Rank
ยฃ3.96 B
Marketcap
ยฃ40.84
Share price
-0.88%
Change (1 day)
-56.71%
Change (1 year)
Sarepta Therapeutics is an American medical research company dedicated to the discovery and development of precisely effective gene therapeutics for the treatment of rare neuromuscular diseases.

Earnings for Sarepta Therapeutics (SRPT)

Earnings in 2024 (TTM): ยฃ0.20 Billion

According to Sarepta Therapeutics 's latest financial reports the company's current earnings are ยฃ1.90 Billion. , an increase over its 2023 earnings that were of -ยฃ0.4 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Sarepta Therapeutics from 1997 to 2024

Annual earnings

Year Earnings Change
2024 ยฃ0.19 B-150.14%
2023 -ยฃ0.4 Billion-24.62%
2022 -ยฃ0.53 Billion64.69%
2021 -ยฃ0.32 Billion-24.25%
2020 -ยฃ0.42 Billion-22.53%
2019 -ยฃ0.55 Billion96.87%
2018 -ยฃ0.28 Billion645.68%
2017 -ยฃ36.82 Million-81.81%
2016 -ยฃ0.21 Billion21.47%
2015 -ยฃ0.17 Billion62.04%
2014 -ยฃ0.11 Billion21.26%
2013 -ยฃ84.79 Million60.93%
2012 -ยฃ52.69 Million93.69%
2011 -ยฃ27.21 Million71.58%
2010 -ยฃ15.86 Million35.06%
2009 -ยฃ11.74 Million-11.62%
2008 -ยฃ13.29 Million-47.02%
2007 -ยฃ25.07 Million0.38%
2006 -ยฃ24.98 Million88.3%
2005 -ยฃ13.27 Million-30.06%
2004 -ยฃ18.97 Million32.69%
2003 -ยฃ14.3 Million-25.52%
2002 -ยฃ19.19 Million64.52%
2001 -ยฃ11.67 Million50.4%
2000 -ยฃ7.76 Million26.44%
1999 -ยฃ6.14 Million8%
1998 -ยฃ5.68 Million102.7%
1997 -ยฃ2.81 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ยฃ0.52 B 164.60%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ0.12 Billion-160.03%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ0.25 Billion-223.59%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ65.84 Million-133.34%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ0.18 Billion-190.31%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ0.28 Billion-239.25%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ0.63 Billion-418.21%๐Ÿ‡บ๐Ÿ‡ธ USA